Somatostatin receptor scintigraphy (SRS) in the detection of liver metastases from gastroenteropancreatic neuroendocrine tumours (GEP).

被引：0
|
作者：
Spanu, A
Schillaci, O
Falchi, A
Marongiu, P
Pisu, N
Madeddu, G
Solinas, ME
Solinas, P
Scopinaro, F
Madeddu, G
机构：
[1] Univ Sassari, I-07100 Sassari, Italy
[2] Univ Roma Tor Vergata, Rome, Italy
[3] Univ Roma La Sapienza, Rome, Italy
来源：
JOURNAL OF NUCLEAR MEDICINE | 2002年 / 43卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1206
引用
收藏
页码：299P / 299P
页数：1
相关论文
共 50 条
  • [21] Detection of somatostatin receptor subtypes 2 and 5 by somatostatin receptor scintigraphy and immunohistochemistry: clinical implications in the diagnostic and therapeutic management of gastroenteropancreatic neuroendocrine tumors
    Sclafani, Francesco
    Carnaghi, Carlo
    Di Tommaso, Luca
    Rodari, Marcello
    Destro, Annarita
    Rimassa, Lorenza
    Giordano, Laura
    Chiti, Arturo
    Roncalli, Massimo
    Santoro, Armando
    TUMORI JOURNAL, 2011, 97 (05): : 620 - 628
  • [22] Somatostatin (SRIF) receptor subtypes in gastroenteropancreatic (GEP) tumors
    Frank, M
    Bruns, C
    Hoyer, D
    Kajdan, U
    Neuhaus, C
    Thoss, S
    Arnold, R
    GASTROENTEROLOGY, 1997, 112 (04) : A1148 - A1148
  • [23] Treatment of neuroendocrine GEP tumours with somatostatin analogues - A review
    Arnold, R
    Simon, B
    Wied, M
    DIGESTION, 2000, 62 : 84 - 91
  • [24] GASTROENTEROPANCREATIC TUMOR IMAGING WITH SOMATOSTATIN RECEPTOR SCINTIGRAPHY
    WIEDENMANN, B
    BADER, HM
    SCHERUBL, H
    FETT, U
    ZIMMER, T
    HAMM, B
    KOPPENHAGEN, K
    RIECKEN, EO
    SEMINARS IN ONCOLOGY, 1994, 21 (05) : 29 - 32
  • [25] Use of somatostatin receptor scintigraphy to image extrahepatic metastases of neuroendocrine tumors
    Frilling, A
    Malago, M
    Martin, H
    Broelsch, CE
    SURGERY, 1998, 124 (06) : 1000 - 1004
  • [26] Feasibility of sornatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours
    Savelli, G
    Lucigani, G
    Seregni, E
    Marchianò, A
    Serafini, G
    Aliberti, G
    Villano, C
    Maccauro, M
    Bombardieri, E
    NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (05) : 445 - 449
  • [27] Advances in the therapy of gastroenteropancreatic-neuroendocrine tumours (GEP-NETs)
    Enrique Grande
    Juan José Díez
    Vanessa Pachón
    Alfredo Carrato
    Clinical and Translational Oncology, 2010, 12 : 481 - 492
  • [28] Advances in the therapy of gastroenteropancreatic-neuroendocrine tumours (GEP-NETs)
    Grande, Enrique
    Jose Diez, Juan
    Pachon, Vanessa
    Carrato, Alfredo
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2010, 12 (07): : 481 - 492
  • [29] ANTIPROLIFERATIVE EFFECT OF ABOVE-LABEL DOSES OF SOMATOSTATIN ANALOGUES (SSA) FOR THE MANAGEMENT OF GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOURS (GEP NET)
    Laskaratos, Faidon-Marios
    Shah, Ruchir
    Banks, Jamie
    Smith, Jack
    Jacobs, Ben
    Galanopoulos, Michail
    Walton, Henry
    Khalifa, Mohamed
    Mandair, Dalvinder
    Caplin, Martyn
    Toumpanakis, Christos
    GASTROENTEROLOGY, 2018, 154 (06) : S707 - S708
  • [30] Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours
    Gotthardt, Martin
    Behe, Martin P.
    Grass, Julia
    Bauhofer, Artur
    Rinke, Anja
    Schipper, Meike L.
    Kalinowski, Marc
    Arnold, Rudolf
    Oyen, Wim J. G.
    Behr, Thomas M.
    ENDOCRINE-RELATED CANCER, 2006, 13 (04) : 1203 - 1211
12345